Showing results (391-400 of 528) with videos related to
Sort By:
Pageof 53
Nature Communications|December 22, 2016
A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuationChristopher C Stobart, Christina A Rostad, Zunlong Ke, et al.Immunity|July 28, 2019
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza HemagglutininSarah F Andrews, Michael J Chambers, Chaim A Schramm, et al.The Journal of Infectious Diseases|November 5, 2019
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K Cunningham, Elizabeth J McFarland, R Leavitt Morrison, et al.The Journal of Infectious Diseases|January 19, 2010
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)Hannah Kibuuka, Robert Kimutai, Leonard Maboko, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2014
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremiaShari N Gordon, Melvin N Doster, Rhonda C Kines, et al.NPJ Vaccines|April 27, 2026
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.Science Immunology|August 8, 2017
Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humansSarah F Andrews, M Gordon Joyce, Michael J Chambers, et al.Plos One|September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.Journal of AIDS & Clinical Research|November 21, 2015
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive IndividualsJonathan D Fuchs, Pierre-Alexandre Bart, Nicole Frahm, et al.Pageof 53